Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
Recruiting
Phase 1
Interventional Study
Chronic Pancreatitis
Mesenchymal Stem Cells
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 42 (estimated)
- Sponsor
- Medical University of South Carolina · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a clinical trial for chronic pancreatitis (CP) patients undergoing total pancreatectomy with islet autotransplantation (TP-IAT). Participants will be randomized to either bone marrow-derived mesenchymal stem cells (MSCs) or control with the standard of care. Participants will be followed for one-year post-transplant.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of CP and scheduled for TP-IAT;
* ≥18 years old;
* Diabetes with HbA1c \<12%.
Exclusion Criteria:
* Patients who are under immunosuppression;
* Pregnant and breastfeeding women.
* Patients who have liver damage based on ALT, AST, and total bilirubin levels (\>3 tim…
Contacts